NCT06367881View on ClinicalTrials.gov

Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

October 31, 2024

Conditions
Neonatal Respiratory Distress SyndromeInflammatory ResponsePremature LungsNeutrophil Extracellular Trap FormationPreterm Birth
Interventions
DRUG

Alveofact

Intratracheal High-dose Alveofact versus Low-dose Alveofact with or without Budesonide

DRUG

Budesonide

Budesonide

Trial Locations (1)

Unknown

RECRUITING

Egypt Neonatal Intensive Care Units (NICUs), Ain Shams University Cairo, Abbasia, Egypt, 11517, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER